Search
for

    Sort by

    Research 91–120 of 457

    1. Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes Journal of experimental and clinical medicine · 2022 · 1 citations
    2. Skin manifestations of hyperandrogenism: an update HORMONES · 2026
    3. Genetic Defects of Female Sexual Differentiation Elsevier eBooks · 2016
    4. Particulate matter 2.5 damages skin cells by inducing oxidative stress, subcellular organelle dysfunction, and apoptosis Archives of Toxicology · 2018 · 215 citations
    5. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome European journal of endocrinology · 2009 · 200 citations
    6. Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature Medicina-lithuania · 2021 · 8 citations
    7. Potential Use of Spin Traps to Control ROS in Antipollution Cosmetics—A Review Cosmetics · 2018 · 4 citations
    8. An update on diagnosis and treatment of female pattern hair loss Expert Review of Dermatology · 2013 · 4 citations
    9. Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia Signal Transduction and Targeted Therapy · 2026
    10. ラット精巣におけるビタミンD 代謝関連遺伝子の発現解析 Institutional Repositories DataBase (IRDB) · 2025
    11. Non-classical Congenital Adrenal Hyperplasia Presenting With Severe Androgenic Alopecia: A Case Report Cureus · 2025
    12. Factors associated with early-onset androgenetic alopecia: A scoping review PLOS ONE · 2024
    13. Generation of Genetically Modified Rats Using CRISPR/Cas9 Genome-Editing System to Reveal Novel Vitamin D Actions Medical Research Archives · 2021
    14. The Role of Propioni Bacterium acnes in Acne Vulgaris Advances in Environmental Biology · 2019
    15. Ursolic acid, a pentacyclic triterpene from Ochrosia elliptica Labill leaves and its role in the management of polycystic ovary syndrome (PCOS) Inflammopharmacology · 2026
    16. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome Frontiers in endocrinology · 2023
    17. Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth International journal of reproductive medicine · 2014 · 222 citations
    18. Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues Molecular and Cellular Endocrinology · 2013 · 48 citations
    19. Recent discoveries and developments of androgen receptor based therapy for prostate cancer MedChemComm · 2015 · 17 citations
    20. Modelling androgen synthesis and action during human sexual differentiation ePrints Soton (University of Southampton) · 2010
    21. Polycystic ovary syndrome Nature Reviews Disease Primers · 2016 · 883 citations
    22. Mixed “Antiandrogenic” Chemicals at Low Individual Doses Produce Reproductive Tract Malformations in the Male Rat Toxicological sciences · 2018 · 49 citations
    23. Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome The Journal of Clinical Endocrinology & Metabolism · 2016 · 40 citations
    24. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    25. What does acne genetics teach us about disease pathogenesis? British Journal of Dermatology · 2019 · 29 citations
    26. Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters BMC Genomics · 2018 · 16 citations
    27. Androgen Receptor in Human Health: A Potential Therapeutic Target Current Drug Targets · 2012 · 12 citations
    28. Discovery of genes and proteins possibly regulating mean wool fibre diameter using cDNA microarray and proteomic approaches Scientific reports · 2020 · 6 citations
    29. A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol BMC Cancer · 2024 · 4 citations
    30. Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment 2015 · 4 citations